Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CK8 antibodies for use in the treatment of colorectal cancers

Anti-CK8 antibodies for use in the treatment of colorectal cancers

US Patent 10533046 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD5 antibodies and methods of use thereof2024
Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 anti2023
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation prof2022
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation prof2022
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies2020
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation prof2017
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation prof2017
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies2017
Pharmaceutical or veterinary antiviral compositions2016
Anti-CD19 antibody having ADCC function with improved glycosylation profile2015
Anti-CK8 antibodies to be used for treating colorectal cancers and identifying m2014
Anti-CK8 antibodies to be used for treating colorectal cancers and identifying m2014